HIV/AIDS Clinical Trials

Showing 1101-1120 of 1,802 trials

Measurement of Plasma and Intracellular Concentrations of Raltegravir

NCT01214486

The primary purpose of this study is to analyze and compare plasma and intracellular concentrations of Raltegravir (RAL) in blood plasma and in peripheral blood mononuclear cells, using high performance liquid chromatography (HPLC).

HIV

University of Nebraska12 participantsStarted Oct 2010

Omaha, Nebraska, United States

COMPLETEDNA

Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV Care

NCT02626351

This study evaluates the impact of a quality improvement (QI) intervention on maternal and child healthcare services in seven primary healthcare (PHC) clinics, in a rural setting of KwaZulu-Natal, South Africa.

PregnancyHIV

University of KwaZulu3,172 participantsStarted Jul 2015

Mtubatuba, KwaZulu-Natal, South Africa

Measurement of Plasma and Intracellular Concentrations of Raltegravir

Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV Care

Related Searches

A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide

Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen

A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)

Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen

Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing

Telephone Support to Improve Adherence to Anti-HIV Medications

HIV Prevention Program for African American Teen Males

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

Comprehensive HIV Prevention Package for MSM in Port Elizabeth

Candidate HIV Vaccine

Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa

Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers